CDC releases new safety advice saying 'the pandemic is not over' as states reopen Eli Lilly, spurred by AI analysis, starts pivotal study of arthritis med Olumiant in COVID-19 FDA yanks chloroquine's emergency OK after data show it doesn't work against COVID-19 China's Sinovac plots pivotal COVID-19 vaccine trial in Brazil after positive phase 2 Biopharma roundup: UK scientists target blood clots in COVID patients; Scripps Research flags new virus mutation AMA's new president talks COVID-19, supply chain issues and racial disparities in healthcare After a turbulent few months, Germany takes a stake in COVID-19 vaccine drugmaker CureVac AstraZeneca taps Catalent for COVID-19 vaccine finishing, packaging at Italian plant Senators call for permanent changes to expand telehealth access post-pandemic Medtronic deploys remote-controlled ventilators to lessen coronavirus exposure Hospital, physician spending in April reaches lowest point in more than a decade: analysis Featured Story | Saturday, June 13, 2020 The Trump administration issued new safety advice for individuals and for those seeking to hold events, warning "the pandemic is not over" even as states increasingly relax restrictions put in place due to the COVID-19 pandemic. read more |
| |
|---|
|
Top Stories Monday, June 15, 2020 Eli Lilly has kicked off a phase 3 trial testing whether Olumiant can improve clinical results in 400 hospitalized COVID-19 patients. It's not the "final step" toward helping more patients survive the illness, a Lilly exec said, but it's "a very important first step." read more Monday, June 15, 2020 It's been more than 2 months since President Donald Trump touted malaria drugs as a possible "game changer" for coronavirus treatment, and the FDA quickly signed off on their emergency use during the pandemic. But now that controlled studies have found no benefit from chloroquine or hydroxychloroquine in COVID-19 patients, the agency is pulling that authorization. read more Monday, June 15, 2020 Another Chinese company is touting an early clinical win for its experimental COVID-19 vaccine. Two doses of Sinovac Biotech's COVID-19 vaccine candidate, dubbed CoronaVac, triggered an immune response in 90% of the 600 trial participants. Now, the company is aiming for a pivotal trial in Brazil to prove the shot works. read more Monday, June 15, 2020 The FDA revoked its emergency authorization of hydroxychloroquine in COVID patients. Imperial College London will target blood clots in phase 1 trials of a Trevena-bought molecule, and Scripps Research flagged a new mutation that boosts the virus' infectivity. Plus, China and the U.S. responded to new infections amid reopening. read more Monday, June 15, 2020 Fierce Healthcare interviewed the new American Medical Association president about everything from upcoming healthcare priorities in an election year to the AMA's recent statement on addressing racism. read more Monday, June 15, 2020 Germany is taking a 23% stake in privately owned CureVac as it preps to push on with work for its mRNA vaccine against the COVID-19 pandemic. read more Monday, June 15, 2020 British drugmaker AstraZeneca is shooting for the moon with its plan to produce 2 billion doses per year of a potential COVID-19 vaccine. To reach that lofty goal, AstraZeneca has struck a deal with New Jersey-based Catalent to help with the final stages of the shot's manufacturing. read more Monday, June 15, 2020 The healthcare industry is speculating about the future of telehealth changes after increased use during the pandemic. A group of 30 senators are calling for Congressional leaders to ensure expanded Medicare reimbursement continues after the pandemic subsidies. read more Monday, June 15, 2020 Medtronic is rolling out free upgrades that will allow each of its ventilators to be controlled from a dedicated device outside of a COVID-19 isolation room. read more Monday, June 15, 2020 Hospitals and physicians saw major declines in spending in April, but nursing home and prescription drug spending fared pretty well, an analysis found. read more |
